Jointechlabs has developed the MiniTC Mini-Stem System, a device that processes adipose tissue for non-surgical regenerative medicine therapies. This technology provides patients with a less invasive alternative for tissue regeneration and repair, addressing the need for effective treatment options without surgical intervention.
Funding
$500K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current surgical regenerative medicine therapies are invasive and require extensive recovery periods. Non-surgical alternatives often lack the efficacy and precision needed for optimal tissue regeneration and repair.
Solution
Jointechlabs offers the MiniTC Adipose Processing System, a point-of-care device designed to process autologous fat (adipose tissue) into purified microfat for injection. This FDA-cleared system provides a less invasive alternative for regenerative medicine therapies, utilizing the patient's own fat for tissue repair. The MiniTC system delivers high-quality microfat, offering advantages over synthetic products and other biologics, with applications in pain management, orthopedics, sports medicine, aesthetics, reconstruction, and wound healing. The closed-loop system ensures simplicity, speed, and adherence to regulatory standards, making it suitable for various clinical settings.
Target Audience
The primary target audience includes cosmetic doctors, surgeons, orthopedists, and other medical professionals seeking effective, minimally invasive solutions for tissue regeneration and repair.
Features
- Processes autologous fat into purified, finely washed microfat for injection.
- Closed-loop, all-in-one disposable medical device.
- Designed for in-clinic use.
- Provides high cell count and viability.
- FDA-cleared for microfat processing.